Whilst cardiovascular outcome trials (such as SUSTAIN-6) have shown reduced major adverse cardiovascular events in people with type 2 diabetes at high cardiovascular risk, this is not a separate UK therapeutic indication for Ozempic
10.1002/ptr.7558 87 LiuT.YangL.GaoH.ZhuoY.TuZ.WangY.et al (2022b)
How It Works It promotes the formation of new blood vessels (angiogenesis), upregulates growth factor receptors, and activates multiple healing pathways
Pause, skip, or cancel anytime via the JumpstartMD app or by contacting Member Support
The medication's effects on satiety and gastric emptying diminish as drug levels decline, potentially triggering increased hunger and food intake
More information on compounded medications here: and on compounded Semaglutide (Ozempic, Wegovy and Rybelsus) here: For more information on the side effects of these medications, please review this article: